Autolus Therapeutics (AUTL) Receivables - Net (2022 - 2025)
Autolus Therapeutics posted quarterly Receivables - Net of $24.0 million for Q4 2025, up 159900.0% year-on-year from N/an in Q4 2024, and down 26.39% on a QoQ basis from $32.6 million in Q3 2025.
Autolus Therapeutics (AUTL) has 4 years of Receivables - Net data on file, last reported at $24.0 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 159900.0% year-over-year to $24.0 million; the trailing twelve-month figure through Dec 2025 stood at $24.0 million (up 159900.0% YoY), and the FY2025 full-year result was $24.0 million, up 159900.0% from the prior year.
- Receivables - Net for Q4 2025 stood at $24.0 million, down from $32.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $32.6 million in Q3 2025 and bottomed at $15000.0 in Q4 2024.
- The 4-year median for Receivables - Net is $7.2 million (2023), against an average of $12.2 million.
- The widest annual swing landed in 2024, when Receivables - Net plunged 86.24%; it then jumped 159900.0% in 2025.
- A 4-year view of Receivables - Net shows it stood at $121000.0 in 2022, then dropped by 9.92% to $109000.0 in 2023, then plunged by 86.24% to $15000.0 in 2024, then surged by 159900.0% to $24.0 million in 2025.
- The last three Receivables - Net figures came in at $24.0 million (Q4 2025), $32.6 million (Q3 2025), and $26.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.00 Mn |
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 32.60 Mn |
| Sep 30, 2025 | 32.60 Mn |
| Jun 30, 2025 | 26.60 Mn |
| Jun 30, 2025 | 26.60 Mn |
| Mar 31, 2025 | 14.32 Mn |
| Mar 31, 2025 | 14.32 Mn |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Dec 31, 2022 | 121,000.00 |